Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 Feb 1;249(3):721–726. doi: 10.1042/bj2490721

Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively.

F J Ballard 1, M Ross 1, F M Upton 1, G L Francis 1
PMCID: PMC1148766  PMID: 2965574

Abstract

1. Competitive binding and receptor cross-linking experiments have been used to examine the receptor-ligand interactions between three bovine insulin-like growth factors (IGF) and monolayer cultures of myoblasts and fibroblasts. 2. Labelled IGF-2 bound predominantly to the type 2 receptor with negligible label cross-linked to the type 1 receptor, notwithstanding the ability of IGF-2 to compete effectively for the binding of IGF-1 to the type 1 receptor. Approx. 100-fold higher concentrations of IGF-1 or the N-terminal truncated (des-Gly-Pro-Glu) IGF-1 (-3N:IGF-1) were required to produce competition equivalent to IGF-2. 3. All IGF peptides, but especially IGF-1, enhanced the binding of labelled IGF-2 to the type 2 receptor of lung fibroblasts. This unusual effect was probably a consequence of the displacement of labelled IGF-2 otherwise bound to a medium protein, a conclusion supported by the demonstration of a 38 kDa membrane protein cross-linked to labelled IGF-2. 4. Both IGF-1 and -3N:IGF-1 bound only to the type 1 IGF receptor in L6 myoblasts, rat vascular smooth-muscle cells and human lung fibroblasts. The peptides competed for labelled IGF-1 binding with potencies in the order -3N:IGF-1 greater than IGF-1 greater than IGF-2 much greater than insulin. Since the IGF peptides were equipotent in skin fibroblasts, it was proposed that the apparently higher affinity of -3N:IGF-1 for receptors in the other cell types was instead a consequence of a low affinity of this peptide for the competing 38 kDa binding protein.

Full text

PDF
723

Images in this article

723Fig. 2.
on p.723
725Fig. 4.
on p.725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams S. O., Kapadia M., Mills B., Daughaday W. H. Release of insulin-like growth factors and binding protein activity into serum-free medium of cultured human fibroblasts. Endocrinology. 1984 Aug;115(2):520–526. doi: 10.1210/endo-115-2-520. [DOI] [PubMed] [Google Scholar]
  2. Ballard F. J., Read L. C., Francis G. L., Bagley C. J., Wallace J. C. Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem J. 1986 Jan 1;233(1):223–230. doi: 10.1042/bj2330223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beguinot F., Kahn C. R., Moses A. C., Smith R. J. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem. 1985 Dec 15;260(29):15892–15898. [PubMed] [Google Scholar]
  4. Carlsson-Skwirut C., Jörnvall H., Holmgren A., Andersson C., Bergman T., Lundquist G., Sjögren B., Sara V. R. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett. 1986 May 26;201(1):46–50. doi: 10.1016/0014-5793(86)80568-3. [DOI] [PubMed] [Google Scholar]
  5. Casella S. J., Han V. K., D'Ercole A. J., Svoboda M. E., Van Wyk J. J. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites. J Biol Chem. 1986 Jul 15;261(20):9268–9273. [PubMed] [Google Scholar]
  6. Clemmons D. R., Elgin R. G., Han V. K., Casella S. J., D'Ercole A. J., Van Wyk J. J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I. J Clin Invest. 1986 May;77(5):1548–1556. doi: 10.1172/JCI112470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Vroede M. A., Tseng L. Y., Katsoyannis P. G., Nissley S. P., Rechler M. M. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media. J Clin Invest. 1986 Feb;77(2):602–613. doi: 10.1172/JCI112343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ewton D. Z., Falen S. L., Florini J. R. The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology. 1987 Jan;120(1):115–123. doi: 10.1210/endo-120-1-115. [DOI] [PubMed] [Google Scholar]
  9. Francis G. L., Read L. C., Ballard F. J., Bagley C. J., Upton F. M., Gravestock P. M., Wallace J. C. Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum. Biochem J. 1986 Jan 1;233(1):207–213. doi: 10.1042/bj2330207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gammeltoft S., Haselbacher G. K., Humbel R. E., Fehlmann M., Van Obberghen E. Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J. 1985 Dec 16;4(13A):3407–3412. doi: 10.1002/j.1460-2075.1985.tb04097.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hossenlopp P., Seurin D., Segovia-Quinson B., Binoux M. Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. FEBS Lett. 1986 Nov 24;208(2):439–444. doi: 10.1016/0014-5793(86)81065-1. [DOI] [PubMed] [Google Scholar]
  12. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem. 1981 Jun 10;256(11):5305–5308. [PubMed] [Google Scholar]
  13. King G. L., Rechler M. M., Kahn C. R. Interactions between the receptors for insulin and the insulin-like growth factors on adipocytes. J Biol Chem. 1982 Sep 10;257(17):10001–10006. [PubMed] [Google Scholar]
  14. Krett N. L., Heaton J. H., Gelehrter T. D. Madin-Darby canine kidney cells display type I and type II insulin-like growth factor (IGF) receptors. Biochem Biophys Res Commun. 1986 Jan 14;134(1):120–127. doi: 10.1016/0006-291x(86)90535-8. [DOI] [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Massagué J., Blinderman L. A., Czech M. P. The high affinity insulin receptor mediates growth stimulation in rat hepatoma cells. J Biol Chem. 1982 Dec 10;257(23):13958–13963. [PubMed] [Google Scholar]
  17. Massagué J., Czech M. P. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982 May 10;257(9):5038–5045. [PubMed] [Google Scholar]
  18. Morgan D. O., Roth R. A. Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factor. Biochem Biophys Res Commun. 1986 Aug 14;138(3):1341–1347. doi: 10.1016/s0006-291x(86)80430-2. [DOI] [PubMed] [Google Scholar]
  19. Oppenheimer C. L., Pessin J. E., Massague J., Gitomer W., Czech M. P. Insulin action rapidly modulates the apparent affinity of the insulin-like growth factor II receptor. J Biol Chem. 1983 Apr 25;258(8):4824–4830. [PubMed] [Google Scholar]
  20. Rechler M. M., Zapf J., Nissley S. P., Froesch E. R., Moses A. C., Podskalny J. M., Schilling E. E., Humbel R. E. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology. 1980 Nov;107(5):1451–1459. doi: 10.1210/endo-107-5-1451. [DOI] [PubMed] [Google Scholar]
  21. Rosenfeld R. G., Conover C. A., Hodges D., Lee P. D., Misra P., Hintz R. L., Li C. H. Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparison of natural, synthetic and recombinant DNA-derived insulin-like growth factor-I. Biochem Biophys Res Commun. 1987 Feb 27;143(1):199–205. doi: 10.1016/0006-291x(87)90650-4. [DOI] [PubMed] [Google Scholar]
  22. Scott C. D., Baxter R. C. Purification and immunological characterization of the rat liver insulin-like growth factor-II receptor. Endocrinology. 1987 Jan;120(1):1–9. doi: 10.1210/endo-120-1-1. [DOI] [PubMed] [Google Scholar]
  23. Thorsson A. V., Hintz R. L., Enberg G., Hall K. Characterization of insulin-like growth factor II binding to human fibroblast monolayer cultures. J Clin Endocrinol Metab. 1985 Feb;60(2):387–391. doi: 10.1210/jcem-60-2-387. [DOI] [PubMed] [Google Scholar]
  24. Van Obberghen-Schilling E., Pouysségur J. Mitogen-potentiating action and binding characteristics of insulin and insulin-like growth factors in Chinese hamster fibroblasts. Exp Cell Res. 1983 Sep;147(2):369–378. doi: 10.1016/0014-4827(83)90219-7. [DOI] [PubMed] [Google Scholar]
  25. de Vroede M. A., Romanus J. A., Standaert M. L., Pollet R. J., Nissley S. P., Rechler M. M. Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation. Endocrinology. 1984 May;114(5):1917–1929. doi: 10.1210/endo-114-5-1917. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES